SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Lepu Biopharma Rises More Than 10% as AP306 Clinical Design Is Presented

Lepu Biopharma shares rose more than 10% intraday; AP306 clinical design was presented.

Related stories